134 related articles for article (PubMed ID: 9305485)
1. Twenty-four-hour intragastric acidity and plasma gastrin during 3-month treatment with omeprazole in healthy subjects.
Delchier JC; Benamouzig R; Stanescu L; Ropert A; Vallot T; Wirquin V; Roudot F; Lamarque D; Hamelin B
Aliment Pharmacol Ther; 1997 Aug; 11(4):747-53. PubMed ID: 9305485
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
Williams MP; Sercombe J; Hamilton MI; Pounder RE
Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
[TBL] [Abstract][Full Text] [Related]
3. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
Harder H; Teyssen S; Stephan F; Pfützer R; Kiel G; Fuchs W; Singer MV
Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.
Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C
Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
[TBL] [Abstract][Full Text] [Related]
6. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects.
Fraser AG; Sawyerr AM; Hudson M; Smith MS; Pounder RE
Aliment Pharmacol Ther; 1996 Aug; 10(4):523-7. PubMed ID: 8853755
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
Hurlimann S; Abbühl B; Inauen W; Halter F
Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects.
Boyce M; Warrington S
Br J Clin Pharmacol; 2013 Nov; 76(5):680-8. PubMed ID: 23432415
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.
Hartmann M; Theiss U; Huber R; Lühmann R; Bliesath H; Wurst W; Lücker PW
Aliment Pharmacol Ther; 1996 Jun; 10(3):359-66. PubMed ID: 8791964
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
Williams MP; Blanshard C; Millson C; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2000 Jun; 14(6):691-9. PubMed ID: 10848651
[TBL] [Abstract][Full Text] [Related]
11. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients.
Lind T; Cederberg C; Olausson M; Olbe L
Gastroenterology; 1990 Dec; 99(6):1593-8. PubMed ID: 2227275
[TBL] [Abstract][Full Text] [Related]
12. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
[TBL] [Abstract][Full Text] [Related]
13. Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.
Faure C; Michaud L; Shaghaghi EK; Popon M; Turck D; Navarro J; Jacqz-Aigrain E
J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):144-8. PubMed ID: 11568514
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four hour intragastric acidity during treatment with oral omeprazole.
Pounder RE; Sharma BK; Walt RP
Scand J Gastroenterol Suppl; 1986; 118():108-17. PubMed ID: 3460165
[TBL] [Abstract][Full Text] [Related]
15. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
Martínek J; Blum AL; Stolte M; Hartmann M; Verdú EF; Lühmann R; Dorta G; Wiesel P
Aliment Pharmacol Ther; 1999 Jan; 13(1):27-34. PubMed ID: 9892876
[TBL] [Abstract][Full Text] [Related]
16. A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer.
Vigneri S; Savarino V; Mela GS; Termini R; Di Mario F; Pantalena M; Zentilin P; Muratore F; Scialabba A; Badalamenti S
Scand J Gastroenterol; 1994 Jun; 29(6):488-92. PubMed ID: 8079104
[TBL] [Abstract][Full Text] [Related]
17. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.
Gillen D; Wirz AA; Ardill JE; McColl KE
Gastroenterology; 1999 Feb; 116(2):239-47. PubMed ID: 9922302
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
[TBL] [Abstract][Full Text] [Related]
19. Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism.
Sagar M; Tybring G; Dahl ML; Bertilsson L; Seensalu R
Gastroenterology; 2000 Sep; 119(3):670-6. PubMed ID: 10982760
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
